Northern Trust’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-16,699
| Closed | -$7K | – | 4331 |
|
|
2018
Q4 | $7K | Hold |
16,699
| – | – | ﹤0.01% | 4226 |
|
|
2018
Q3 | $16K | Hold |
16,699
| – | – | ﹤0.01% | 4228 |
|
|
2018
Q2 | $40K | Buy |
16,699
+4,264
| +34% | +$10.4K | ﹤0.01% | 4151 |
|
|
2018
Q1 | $29K | Sell |
12,435
-100
| -0.8% | -$252 | ﹤0.01% | 4142 |
|
|
2017
Q4 | $30K | Sell |
12,535
-1,606
| -11% | -$4.44K | ﹤0.01% | 4126 |
|
|
2017
Q3 | $44K | Hold |
14,141
| – | – | ﹤0.01% | 4074 |
|
|
2017
Q2 | $57K | Buy |
14,141
+2,165
| +18% | +$9.43K | ﹤0.01% | 4063 |
|
|
2017
Q1 | $45K | Buy |
+11,976
| New | +$37.6K | ﹤0.01% | 4067 |
|
|
2016
Q4 | – | Sell |
-5,721
| Closed | -$36K | – | 4264 |
|
|
2016
Q3 | $36K | Sell |
5,721
-1,747
| -23% | -$10.8K | ﹤0.01% | 4051 |
|
|
2016
Q2 | $34K | Sell |
7,468
-40,364
| -84% | -$264K | ﹤0.01% | 4071 |
|
|
2016
Q1 | $502K | Buy |
47,832
+2,336
| +5% | +$46.4K | ﹤0.01% | 3470 |
|
|
2015
Q4 | $1.34M | Sell |
45,496
-310
| -0.7% | -$9.37K | ﹤0.01% | 3221 |
|
|
2015
Q3 | $1.45M | Buy |
45,806
+10,561
| +30% | +$505K | ﹤0.01% | 3195 |
|
|
2015
Q2 | $2.09M | Buy |
35,245
+1,009
| +3% | +$71.2K | ﹤0.01% | 3040 |
|
|
2015
Q1 | $3.66M | Buy |
34,236
+228
| +0.7% | +$21.7K | ﹤0.01% | 2710 |
|
|
2014
Q4 | $3.19M | Sell |
34,008
-1,378
| -4% | -$131K | ﹤0.01% | 2786 |
|
|
2014
Q3 | $2.72M | Buy |
35,386
+16,508
| +87% | +$1.3M | ﹤0.01% | 2896 |
|
|
2014
Q2 | $1.7M | Sell |
18,878
-510
| -3% | -$31.3K | ﹤0.01% | 3171 |
|
|
2014
Q1 | $1.04M | Sell |
19,388
-818
| -4% | -$27K | ﹤0.01% | 3387 |
|
|
2013
Q4 | $509K | Buy |
20,206
+20
| +0.1% | +$476 | ﹤0.01% | 3516 |
|
|
2013
Q3 | $549K | Buy |
20,186
+5,745
| +40% | +$185K | ﹤0.01% | 3449 |
|
|
2013
Q2 | $521K | Buy |
+14,441
| New | +$541K | ﹤0.01% | 3446 |
|
Northern Trust's PTX Position: Q1 2019 in Review
Northern Trust sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 16,699 shares — an estimated $7K sold.
Northern Trust first reported a position in PTX in Q2 2013 and held it in 22 quarters. The position peaked at $3.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Northern Trust reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Northern Trust sold 16,699 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $7K.
- Northern Trust first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 22 quarters.
- Northern Trust's Pernix Therapeutics Holdings, Inc. position peaked at $3.66M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Northern Trust's 13F filing for Q1 2019, filed 13 May 2019.